Research Topics
| J Steven McDougalSummaryAffiliation: Centers for Disease Control and Prevention Country: USA Publications
| Collaborators
|
Detail Information
Publications
Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassayJ Steven McDougal
Division of HIV AIDS Prevention, National Center for HIV AIDS, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
AIDS Res Hum Retroviruses 22:945-52. 2006..Cross-sectional HIV incidence estimation circumvents many of the drawbacks associated with longitudinal cohort studies, but there are test-specific limitations that should be considered in the design of population surveys...- Surveillance for HIV-1 incidence using tests for recent infection in resource-constrained countriesJ Steven McDougal
National Center for HIV AIDS, STD, TB Prevention, Centers for Disease Control and Prevention, US Public Health Service, Atlanta, GA 30333, USA
AIDS 19:S25-30. 2005.... - Determination of mean recency period for estimation of HIV type 1 Incidence with the BED-capture EIA in persons infected with diverse subtypesBharat S Parekh
Division of Global AIDS Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
AIDS Res Hum Retroviruses 27:265-73. 2011..8 OD-n by 480 days. The determination of ? with more data and new methodology suggests that ? of the BED-CEIA varies between different subtypes and/or populations. These estimates for ? may affect incidence estimates in various studies... - HIV type 1 incidence estimates by detection of recent infection from a cross-sectional sampling of injection drug users in Bangkok: use of the IgG capture BED enzyme immunoassayDale J Hu
Division of HIV AIDS Prevention and Division of AIDS, STD, TB Laboratory Research, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
AIDS Res Hum Retroviruses 19:727-30. 2003.... - Performance characteristics of the immunoglobulin G-capture BED-enzyme immunoassay, an assay to detect recent human immunodeficiency virus type 1 seroconversionTrudy Dobbs
HIV Immunology and Diagnostics Branch, Mailstop D12, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, USA
J Clin Microbiol 42:2623-8. 2004..This information provides baseline data for the successful transfer of BED-CEIA to other laboratories and the use of BED-CEIA for the detection of recent HIV seroconversion and the calculation of incidence estimates worldwide... - Assessment of BED HIV-1 incidence assay in seroconverter cohorts: effect of individuals with long-term infection and importance of stable incidenceJanet M McNicholl
Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
PLoS ONE 6:e14748. 2011..We sought to assess its performance in three longitudinal cohorts from Thailand where HIV-1 CRF01_AE and subtype B' dominate the epidemic... - Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidenceBharat S Parekh
Division of AIDS, STD, TB Laboratory Research, and Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
AIDS Res Hum Retroviruses 18:295-307. 2002..This assay should be useful for detecting recent HIV-1 infection and for estimating incidence among diverse HIV-1 subtypes worldwide... - Application of laboratory methods for estimation of HIV-1 incidenceBharat S Parekh
HIV Immunology and Diagnostics Branch, Division of HIV AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Mailstop D 12, 1600 Clifton Road, Atlanta, GA 30333, USA
Indian J Med Res 121:510-8. 2005.... - Human immunodeficiency virus (HIV) seropositivity among uninfected HIV vaccine recipientsMarta Louise Ackers
HIV Vaccine Section, Epidemiology Branch, Division of HIV AIDS Prevention Surveillance and Epidemiology, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
J Infect Dis 187:879-86. 2003..The potential for vaccine recipients being misclassified as HIV infected increased with vaccine complexity... - A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. III. Comparative performance characteristics of academic and manufacturers' laboratoriesMarvin J Fritzler
Standardization Committee in Rheumatic and Related Disorders, International Union of Immunological Societies, Atlanta, Georgia, USA
J Rheumatol 30:2374-81. 2003..To analyze the performance of different commercial enzyme immunoassay (EIA) kits for measuring antinuclear antibodies (ANA) specific for dsDNA, SSB/La, Sm, and Scl-70... - Guidelines for performing single-platform absolute CD4+ T-cell determinations with CD45 gating for persons infected with human immunodeficiency virus. Centers for Disease Control and PreventionFrancis F Mandy
Bureau of HIV/AIDS, STD and TB, Population and Public Health Branch, Health Canada, Ottawa, Ontario, Canada
MMWR Recomm Rep 52:1-13. 2003..The new recommendations address concerns specific to the implementation of SPT as well as other general topics such as laboratory safety and specimen handling... - A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. II. Potential for quantitation of antibody contentEng M Tan
Autoantibody Standardization Committee in Rheumatic and Related Disorders of the International Union of Immunological Societies, The World Health Organization, The Arthritis Foundation, and Centers for Disease Control and Prevention
J Rheumatol 29:68-74. 2002..Improved EIA kits would lend themselves to reliable quantitation of antibody levels in human sera and help to determine whether serial measurement of antibody levels might be useful in monitoring disease activity...